Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis

References

• Hong G, Rui G, Zhang D, et al. A smartphone-assisted pressure-measuring-based diagnosis system for acute myocardial infarction diagnosis. Int J Nanomedicine. 2019;14:2451–2464. doi:10.2147/IJN.S19754131040668
   PubMedGoogle Scholar
• Kavalieratos D, Gelfman LP, Tycon LE, et al. Palliative care in heart failure: rationale, evidence, and future priorities. J Am Coll Cardiol. 2017;70(15):1919–1930. doi:10.1016/j.jacc.2017.08.03628982506
   PubMed Web of Science ®Google Scholar
• Reddy K, Khaliq A, Henning RJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol. 2015;7(5):243–276.26015857
   PubMed Web of Science ®Google Scholar
• Miyagi Y, Zeng F, Huang XP, et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials. 2010;31(30):7684–7694. doi:10.1016/j.biomaterials.2010.06.04820659765
   PubMedGoogle Scholar
• Jiang HK, Wang YH, Sun L, et al. Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics. Int J Mol Sci. 2014;15(4):5304–5322. doi:10.3390/ijms1504530424675698
   PubMed Web of Science ®Google Scholar
• Morciano G, Bonora M, Campo G, et al. Mechanistic role of mPTP in ischemia-reperfusion injury. Adv Exp Med Biol. 2017;982:169–189. doi:10.1007/978-3-319-55330-6_928551787
   PubMed Web of Science ®Google Scholar
• Webster KA. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 2012;8(6):863–884. doi:10.2217/fca.12.5823176689
   PubMedGoogle Scholar
• Narula J, Pandey P, Arbustini E, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A. 1999;96(14):8144–8149. doi:10.1073/pnas.96.14.814410393962
   PubMed Web of Science ®Google Scholar
• Wenjun H, Jing W, Tao L, et al. The protective effect of puerarin on Myocardial Infarction Reperfusion Injury (MIRI): a meta-analysis of randomized studies in rat models. Med Sci Monit. 2015;21:1700–1706. doi:10.12659/MSM.89431226067875
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zong J, Zhou H, et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. J Cardiol. 2014;63(1):73–81. doi:10.1016/j.jjcc.2013.06.00823906530
   PubMed Web of Science ®Google Scholar
• Yang B, Gao Q, Yao H, Xia Q. Mitochondrial mechanism of cardioprotective effect of puerarin against H202-stress in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008;24(4):399–404.21158136
   PubMedGoogle Scholar
• Ma Y, Gai Y, Yan J, Li J, Zhang Y. Puerarin attenuates anoxia/reoxygenation injury through enhancing Bcl-2 associated athanogene 3 expression, a modulator of apoptosis and autophagy. Med Sci Monit. 2016;22:977–983. doi:10.12659/msm.89737927011313
   PubMedGoogle Scholar
• Battogtokh G, Choi YS, Kang DS, et al. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Acta Pharm Sin B. 2018;8(6):862–880. doi:10.1016/j.apsb.2018.05.00630505656
   PubMed Web of Science ®Google Scholar
• Zielonka J, Joseph J, Sikora A, et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev. 2017;117(15):10043–10120. doi:10.1021/acs.chemrev.7b0004228654243
   PubMed Web of Science ®Google Scholar
• Porteous CM, Logan A, Evans C, et al. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochim Biophys Acta. 2010;1800(9):1009–1017. doi:10.1016/j.bbagen.2010.06.00120621583
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano JS, Weissig V. Treatment strategies that enhance the efficacy and selectivity of mitochondria-targeted anticancer agents. Int J Mol Sci. 2015;16(8):17394–17421. doi:10.3390/ijms16081739426230693
   PubMed Web of Science ®Google Scholar
• Park H, Kim HS, Hong YJ, et al. Therapeutic effect of fimasartan in a rat model of myocardial infarction evaluated by cardiac positron emission tomography with [(18)F]FPTP. Chonnam Med J. 2019;55(2):109–115. doi:10.4068/cmj.2019.55.2.10931161123
   PubMedGoogle Scholar
• Kim DY, Kim HS, Min JJ. Radiosynthesis and evaluation of 18F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography. Nucl Med Commun. 2015;36(7):747–754. doi:10.1097/MNM.000000000000031525850717
   PubMedGoogle Scholar
• Lukyanov AN, Hartner WC, Torchilin VP. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release. 2004;94(1):187–193. doi:10.1016/j.jconrel.2003.10.00814684282
   PubMed Web of Science ®Google Scholar
• Kohay H, Sarisozen C, Sawant R, Jhaveri A, Torchilin VP, Mishael YG. PEG-PE/clay composite carriers for doxorubicin: effect of composite structure on release, cell interaction and cytotoxicity. Acta Biomater. 2017;55:443–454. doi:10.1016/j.actbio.2017.04.00828400314
   PubMed Web of Science ®Google Scholar
• Gao H, Liu J, Yang C, et al. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles. Int J Nanomedicine. 2013;8:4229–4246. doi:10.2147/IJN.S5156624235825
   PubMed Web of Science ®Google Scholar
• Li W, Wu J, Zhang J, et al. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv. 2018;25(1):827–837. doi:10.1080/10717544.2018.145576329587545
   PubMed Web of Science ®Google Scholar
• Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release. 2012;159(3):393–402. doi:10.1016/j.jconrel.2012.01.00922286008
   PubMed Web of Science ®Google Scholar
• Wei S, Sun T, Du J, Zhang B, Xiang D, Li W. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro. Oncol Rep. 2018;40(6):3213–3222. doi:10.3892/or.2018.672330272303
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhao J, Tse HF, Le XC, Rong J. Plant natural products calycosin and gallic acid synergistically attenuate neutrophil infiltration and subsequent injury in isoproterenol-induced myocardial infarction: a possible role for leukotriene B4 12-hydroxydehydrogenase? Oxid Med Cell Longev. 2015;2015:434052. doi:10.1155/2015/65975026265982
   PubMedGoogle Scholar
• Bi Y, Liu L, Lu Y, et al. T7 peptide-functionalized PEG-PLGA micelles loaded with carmustine for targeting therapy of glioma. ACS Appl Mater Interfaces. 2016;8(41):27465–27473. doi:10.1021/acsami.6b0557227466824
   PubMedGoogle Scholar
• Zuo T, Guan Y, Chang M, et al. RGD(Arg-Gly-Asp) internalized docetaxel-loaded pH sensitive liposomes: preparation, characterization and antitumor efficacy in vivo and in vitro. Colloids Surf B Biointerfaces. 2016;147:90–99. doi:10.1016/j.colsurfb.2016.07.05627497073
   PubMedGoogle Scholar
• Abouzeid AH, Patel NR, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. Int J Pharm. 2014;464(1–2):178–184. doi:10.1016/j.ijpharm.2014.01.00924440402
   PubMedGoogle Scholar
• Roby A, Erdogan S, Torchilin VP. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm. 2006;62(3):235–240. doi:10.1016/j.ejpb.2005.09.01016326084
   PubMed Web of Science ®Google Scholar
• Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297–304. doi:10.1016/j.biopha.2017.02.02928236703
   PubMed Web of Science ®Google Scholar
• Choi YS, Kwon K, Yoon K, Huh KM, Kang HC. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: subcellular targeting, therapeutic, and imaging potentials. Int J Pharm. 2017;520(1–2):195–206. doi:10.1016/j.ijpharm.2017.02.01328179191
   PubMedGoogle Scholar
• Zhang E, Zhang C, Su Y, Cheng T, Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today. 2011;16(3–4):140–146.21182981
   PubMed Web of Science ®Google Scholar
• Galliani M, Tremolanti C, Signore G. Nanocarriers for protein delivery to the cytosol: assessing the endosomal escape of Poly(Lactide-co-Glycolide)-Poly(Ethylene Imine) nanoparticles. Nanomaterials. 2019;9(4):Apr. doi:10.3390/nano9071000
   Web of Science ®Google Scholar
• Sonawane ND, Szoka FC Jr, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 2003;278(45):44826–44831. doi:10.1074/jbc.M30864320012944394
   PubMed Web of Science ®Google Scholar
• Marrache S, Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci U S A. 2012;109(40):16288–16293. doi:10.1073/pnas.121009610922991470
   PubMed Web of Science ®Google Scholar
• Moe GW, Marin-Garcia J. Role of cell death in the progression of heart failure. Heart Fail Rev. 2016;21(2):157–167. doi:10.1007/s10741-016-9532-026872675
   PubMed Web of Science ®Google Scholar
• Jose Corbalan J, Vatner DE, Vatner SF. Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol. 2016;111(3):31. doi:10.1007/s00395-016-0549-227043720
   PubMed Web of Science ®Google Scholar
• Huang P, Wang L, Li Q, et al. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2019. doi:10.1093/cvr/cvz139
   Web of Science ®Google Scholar
• Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, et al. Animal models of cardiovascular diseases. J Biomed Biotechnol. 2011;2011:497841. doi:10.1155/2011/49784121403831
   PubMedGoogle Scholar
• Chen J, Ceholski DK, Liang L, Fish K, Hajjar RJ. Variability in coronary artery anatomy affects consistency of cardiac damage after myocardial infarction in mice. Am J Physiol Heart Circulatory Physiol. 2017;313(2):H275–H282. doi:10.1152/ajpheart.00127.2017
   PubMed Web of Science ®Google Scholar
• Nichtova Z, Novotova M, Kralova E, Stankovicova T. Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol. Gen Physiol Biophys. 2012;31(2):141–151. doi:10.4149/gpb_2012_01522781817
   PubMed Web of Science ®Google Scholar
• Lobo Filho HG, Ferreira NL, Sousa RB, Carvalho ER, Lobo PL, Lobo Filho JG. Experimental model of myocardial infarction induced by isoproterenol in rats. Rev Bras Cirurgia Cardiovasc. 2011;26(3):469–476. doi:10.5935/1678-9741.20110024
   PubMedGoogle Scholar
• Li M, Song W, Tang Z, et al. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. ACS Appl Mater Interfaces. 2013;5(5):1781–1792. doi:10.1021/am303073u23410916
   PubMed Web of Science ®Google Scholar
• Smith RA, Porteous CM, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A. 2003;100(9):5407–5412. doi:10.1073/pnas.093124510012697897
   PubMed Web of Science ®Google Scholar
• Goffart S, von Kleist-Retzow JC, Wiesner RJ. Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc Res. 2004;64(2):198–207. doi:10.1016/j.cardiores.2004.06.03015485678
   PubMed Web of Science ®Google Scholar